|
1
|
Hilchie AL, Vale R, Zemlak TS and Hoskin
DW: Generation of a hematologic malignancy-selective membranolytic
peptide from the antimicrobial core (RRWQWR) of bovine
lactoferricin. Exp Mol Pathol. 95:192–198. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sato H and Feix JB: Peptide-membrane
interactions and mechanisms of membrane destruction by amphipathic
α-helical antimicrobial peptides. Biochim Biophys Acta.
1758:1245–1256. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Koczulla AR and Bals R: Antimicrobial
peptides: Current status and therapeutic potential. Drugs.
63:389–406. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Homayouni-Tabrizi M, Asoodeh A, Soltani M
and Forghanifard MM: Antimicrobial peptide Brevinin-2R induces the
secretion of a pro-inflamatory cytokine in HepG2 cells. J Bas Res
Med Sci. 2:23–29. 2015.
|
|
5
|
Karadag R, Bayram N, Oguztuzun S,
Bayramlar H, Bozer B, Simsek G and Rapuano CJ: An investigation of
human beta-defensins and cathelicidin expression in patients with
pterygium. Arq Bras Oftalmol. 80:277–280. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhuravel E, Shestakova T, Efanova O,
Yusefovich Y, Lytvin D, Soldatkina M and Pogrebnoy P: Human
beta-defensin-2 controls cell cycle in malignant epithelial cells:
In vitro study. Exp Oncol. 33:114–120. 2011.PubMed/NCBI
|
|
7
|
He M, Zhang H, Li Y, Wang G, Tang B, Zhao
J, Huang Y and Zheng J: Cathelicidin-derived antimicrobial peptides
inhibit zika virus through direct inactivation and interferon
pathway. Front Immunol. 9:7222018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vermes I, Haanen C and Reutelingsperger C:
Flow cytometry of apoptotic cell death. J Immunol Methods.
243:167–190. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schleicher SM, Moretti L, Varki V and Lu
B: Progress in the unraveling of the endoplasmic reticulum
stress/autophagy pathway and cancer: Implications for future
therapeutic approaches. Drug Resist Updat. 13:79–86. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Voiculescu VM, Caruntu C, Solomon I, Lupu
M, Ilie MA, Boda D, Constantin C and Neagu M: Squamous cell
carcinoma: Biomarkers and potential therapeutic targetsHuman Skin
Cancers-Pathways, Mechanisms, Targets and Treatments. Blumenberg M:
IntechOpen; London: pp. 135–159. 2018
|
|
11
|
Neagu M, Caruntu C, Constantin C, Boda D,
Zurac S, Spandidos DA and Tsatsakis AM: Chemically induced skin
carcinogenesis: Updates in experimental models (Review). Oncol Rep.
35:2516–2528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boda D: Cellomics as integrative omics for
cancer. Curr Proteomics. 10:237–245. 2013. View Article : Google Scholar
|
|
13
|
Neagu M, Constantin C, Tanase C and Boda
D: Patented biomarker panels in early detection of cancer. Recent
Pat Biomark. 1:10–24. 2011. View Article : Google Scholar
|
|
14
|
Kraskiewicz H and FitzGerald U:
InterfERing with endoplasmic reticulum stress. Trends Pharmacol
Sci. 33:53–63. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zinszner H, Kuroda M, Wang X, Batchvarova
N, Lightfoot RT, Remotti H, Stevens JL and Ron D: CHOP is
implicated in programmed cell death in response to impaired
function of the endoplasmic reticulum. Genes Dev. 12:982–995. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park SH, Choi HJ, Yang H, Do KH, Kim J,
Lee DW and Moon Y: Endoplasmic reticulum stress-activated C/EBP
homologous protein enhances nuclear factor-kappaB signals via
repression of peroxisome proliferator-activated receptor gamma. J
Biol Chem. 285:35330–35339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lupu M, Caruntu A, Caruntu C, Papagheorghe
LML, Ilie MA, Voiculescu V, Boda D, Constantin C, Tanase C, Sifaki
M, Drakoulis N, Mamoulakis C, Tzanakakis G, Neagu M, Spandidos DA,
Izotov B and Tsatsakis A: Neuroendocrine factors: The missing link
in non melanoma skin cancer. Oncol Rep. 38:1327–13401. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boda D, Docea AO, Calina D, Ilie MA,
Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu DE,
Voiculescu V, et al: Human papilloma virus: Apprehending the link
with carcinogenesis and unveiling new research avenues (Review).
Int J Oncol. 52:637–655. 2018.PubMed/NCBI
|
|
19
|
Solomon I, Voiculescu VM, Caruntu C, Lupu
M, Popa A, Ilie MA, Albulescu R, Caruntu A, Tanase C, Constantin C,
et al: Neuroendocrine factors and head and neck squamous cell
carcinoma: An affair to remember. Dis Markers. 2018:97878312018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Healy SJ, Gorman AM, Mousavi-Shafaei P,
Gupta S and Samali A: Targeting the endoplasmic reticulum-stress
response as an anticancer strategy. Eur J Pharmacol. 625:234–246.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cioplea M, Caruntu C, Zurac S, Bastian A,
Sticlaru L, Cioroianu A, Boda D, Jugulete G, Nichita L and Popp C:
Dendritic cell distribution in mycosis fungoides vs. inflammatory
dermatosis and other T-cell skin lymphoma. Oncol Lett.
17:4055–4059. 2019.PubMed/NCBI
|
|
22
|
Del Poeta G, Venditti A, Del Principe MI,
Maurillo L, Buccisano F, Tamburini A, Cox MC, Franchi A, Bruno A,
Mazzone C, et al: Amount of spontaneous apoptosis detected by
Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).
Blood. 101:2125–2131. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mitsuishi Y, Taguchi K, Kawatani Y,
Shibata T, Nukiwa T, Aburatani H, Yamamoto M and Motohashi H: Nrf2
redirects glucose and glutamine into anabolic pathways in metabolic
reprogramming. Cancer Cell. 22:66–79. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ren D, Villeneuve NF, Jiang T, Wu T, Lau
A, Toppin HA and Zhang DD: Brusatol enhances the efficacy of
chemotherapy by inhibiting the Nrf2-mediated defense mechanism.
Proc Natl Acad Sci USA. 108:1433–1438. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Magesh S, Chen Y and Hu L: Small molecule
modulators of Keap1-Nrf2-ARE pathway as potential preventive and
therapeutic agents. Med Res Rev. 32:687–726. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kong D, Park EJ, Stephen AG, Calvani M,
Cardellina JH, Monks A, Fisher RJ, Shoemaker RH and Melillo G:
Echinomycin, a small-molecule inhibitor of hypoxia-inducible
factor-1 DNA-binding activity. Cancer Res. 65:9047–9055. 2005.
View Article : Google Scholar : PubMed/NCBI
|
